Meetings - The ASCO Post

At the 2022 Summit on Cancer Health Disparities in Seattle, leaders from five of the leading professional societies in cancer discussed their respective organizations’ current initiatives toward impro...

COVID-19

By Meg Barbor, MPH / June 25, 2022 / 2022 Summit on Cancer Health Disparities

Looking Back at Telemedicine During the COVID-19 Era: Lessons Learned and Disparities Identified

Telemedicine stepped up to the plate when the COVID-19 pandemic swept the globe. Oncology providers—and practitioners in all specialties—had to rapidly adapt to a telemedicine format when face-to-face...

Issues in Oncology

By Meg Barbor, MPH / June 25, 2022 / 2022 Summit on Cancer Health Disparities

Elevating Cancer Care in the United States for All: Current Challenges and Potential Solutions

Optimizing oncology care in the United States will require making state-of-the-art care more accessible to all. Delivering quality, equitable cancer care is undoubtedly a challenge in a country as lar...

2022 Summit on Cancer Health Disparities

Initiatives by Professional Oncology Organizations Focus on Improving Equitable Cancer Care

Looking Back at Telemedicine During the COVID-19 Era: Lessons Learned and Disparities Identified

Elevating Cancer Care in the United States for All: Current Challenges and Potential Solutions

First-Line NALIRIFOX Regimen Improves Overall Survival in Metastatic Pancreatic Cancer

Subset of Patients With Advanced Gastric/GEJ Cancer May Benefit From CLDN18.2-Targeted Drug Zolbetuximab

Momelotinib May Effectively Reduce Anemia and Other Symptoms for Patients With Myelofibrosis

Subcutaneous Epcoritamab for Relapsed or Refractory Large B-Cell Lymphoma

FDA Approves Mosunetuzumab-axgb, a First-in-Class Bispecific Antibody, in Relapsed or Refractory Follicular Lymphoma